Johnson & Johnson is investing more than $55 billion in the U.S. over the next four years in manufacturing, research and development, and technology. This represents a 25% increase in investment compared to the previous four years and builds on the company’s U.S. investment levels resulting from the passage of the 2017 Tax Cuts & Jobs Act. “This announcement accelerates our nearly 140-year legacy as an American innovation engine tackling the world’s toughest healthcare challenges,” sa...